Evidence map›Paper›PMID 39673761›Full record

ArticleAmerican journal of epidemiology2025

Towards robust causal inference in epidemiologic research: employing double cross-fit TMLE in right heart catheterization data.

Momenul Haque Mondol, Mohammad Ehsanul Karim

Abstract read
In one paragraph

Article in American journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Momenul Haque MondolSchool of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0002-2624-2118
Mohammad Ehsanul KarimSchool of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0002-0346-2871

Funding

Discovery Launch Supplement 20R12709M.E.K.'s Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery 20R01603
6 · The paper itself

Abstract

Within epidemiologic research, estimating treatment effects from observational data presents notable challenges. Targeted maximum likelihood estimation (TMLE) emerges as a robust method, addressing these challenges by accurately modeling treatment effects. This approach uniquely combines the precision of correctly specified models with the versatility of data-adaptive, flexible machine learning algorithms. Despite its effectiveness, TMLE's integration of complex algorithms can introduce bias and undercoverage. This issue is addressed through the double cross-fit TMLE (DC-TMLE) approach, enhancing accuracy and reducing biases inherent in observational studies. However, DC-TMLE's potential remains underexplored in epidemiologic research, primarily due to the lack of comprehensive methodologic guidance and the complexity of its computational implementation. Recognizing this gap, our article contributes a detailed, reproducible guide for implementing DC-TMLE in R, aimed specifically at epidemiologic applications. We demonstrate the utility of this method using an openly available clinical data set, underscoring its relevance and adaptability for robust epidemiologic analysis. This guide aims to facilitate broader adoption of DC-TMLE in epidemiologic studies, promoting more accurate and reliable treatment effect estimations in observational research.

Indexed as

Cardiac CatheterizationCausalityEpidemiologic StudiesAlgorithmsBiasHumansLikelihood FunctionsObservational Studies as Topiccausal inferencedouble cross-fitmachine learningtargeted maximum likelihood estimation

Identifiers

PMID39673761
PMCPMC12527275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.